Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Assessing the MUC5B Promoter Variant in a Large Cohort of Systemic Sclerosis-Associated Interstitial Lung Disease, Carlos Rosa-Baez, Carlos Rangel-Pelaez, Inmaculada Rodriguez-Martin, et al.
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration, Lee S Rosen, Christian Ottensmeier, Maria Hawkins, et al.
Improved Survival and Decreased Cancer Deaths in Young Adults With Cancer After Passage of the Affordable Care Act Dependent Coverage Expansion, Michael Roth, Clark R Andersen, Amy Berkman, et al.
Immunological Biomarkers of Response and Resistance to Treatment With Cabozantinib and Nivolumab in Recurrent Endometrial Cancer, Vladimir Roudko, Diane Marie Del Valle, Emir Radkevich, et al.
The CGAS-STING1 Pathway as a Mediator of Innate Immune Response in Cardiovascular Disease, Leila Rouhi, Priyatansh Gurha, and Ali J Marian
Advancing Alzheimer's Research by Improving Disease Modeling of Secondary Tauopathy, Ethan R Roy and Wei Cao
Pexidartinib and Standard Neoadjuvant Therapy in the Adaptively Randomized I-SPY2 Trial for Early Breast Cancer, Hope S Rugo, Mike Campbell, Christina Yau, et al.
Correction: New Insights Into the Mechanisms of Electroconvulsive Therapy in Treatment-Resistant Depression, Ana C Ruiz, Abdul Haseeb, William Baumgartner, et al.
New Insights Into the Mechanisms of Electroconvulsive Therapy in Treatment-Resistant Depression, Ana C Ruiz, Abdul Haseeb, William Baumgartner, et al.
Senescence Caused by Telomerase Inactivation in Myeloid, Mesenchymal, and Endothelial Cells Has Distinct Effects on Cancer Progression, Joseph Rupert, Zhanguo Gao, Yongmei Yu, et al.
Deep Learning-Based Automatic Segmentation of Cerebral Infarcts on Diffusion MRI, Wi-Sun Ryu, Dawid Schellingerhout, Jonghyeok Park, et al.
Machine-Learning Driven Strategies for Adapting Immunotherapy in Metastatic NSCLC, Maliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, et al.
Causal AI-Based Clinical and Radiomic Analysis for Optimizing Patient Selection in Combined Immunotherapy and Sabr in Early-Stage NSCLC: A Secondary Analysis of the Phase II I-SABR Trial, Maliazurina B Saad, Eman Showkatian, Vivek Verma, et al.
Reduced Computed Tomography Scan Speed Improves Alignment Errors for Patients Undergoing Thoracic Stereotactic Body Radiation Therapy, Ramaswamy Sadagopan, Rachael M Martin-Paulpeter, Christopher R Peeler, et al.
The microRNA miR-30a Blocks Adipose Tissue Fibrosis Accumulation in Obesity, Michael J Bolt, Sung Yun Jung, Kang Ho Kim, et al.
Longitudinal Analysis of Gut Microbiome and Metabolome Correlates of Response and Toxicity With Idecabtagene Vicleucel, Satabdi Saha, Lubna Rehman, Abdur Rehman, et al.
Phase 1 Trial of Hypofractionated Stereotactic Re-Irradiation in Combination With Nivolumab, Ipilimumab, and Bevacizumab for Recurrent High-Grade Gliomas, Solmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
Systemic Antitumor Immune Response of Doped Yttria Nanoscintillators Under Low-Dose X-Ray Irradiation, Onur Sahin, Yuri Mackeyev, Geraldine V Vijay, et al.
IDH Status Dictates oHSV Mediated Metabolic Reprogramming Affecting Anti-tumor Immunity, Upasana Sahu, Matthew P Mullarkey, Sara A Murphy, et al.
Misfolded Amyloid-Beta Conformational Variants (Strains) As Drivers of Alzheimer's Disease Neuropathology, Salvatore Saieva and Rodrigo Morales
Machine Learning Predicting Acute Pain and Opioid Dose in Radiation Treated Oropharyngeal Cancer Patients, Vivian Salama, Laia Humbert-Vidan, Brandon Godinich, et al.
Performance Comparison of 10 State-of-the-Art Machine Learning Algorithms for Outcome Prediction Modeling of Radiation-Induced Toxicity, Ramon M Salazar, Saurabh S Nair, Alexandra O Leone, et al.
Crowd-Sourced Benchmarking of Single-Sample Tumor Subclonal Reconstruction, Adriana Salcedo, Maxime Tarabichi, Alex Buchanan, et al.
Inhibition of Methylthioadenosine Phosphorylase Protects From Experimental Acute Kidney Injury, Afaf Saliba, Yidong Chen, Jonathan W Nelson, et al.
Long-Term Follow-Up and Combined Phase 2 Results of Eprenetapopt and Azacitidine in Patients With TP53 Mutant MDS/AML, David A Sallman, Rami S Komrokji, Amy E Dezern, et al.